simendan has been researched along with Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boening, A; Heep, M; Hemmerich, C; Niemann, B; Schlüter, KD; Taghiyev, ZT; Welk, E | 1 |
| Aalto-Setälä, K; Gaballah, M; Kallio, P; Kreutzer, J; Mäki, AJ; Penttinen, K | 1 |
| Abrass, CK; Hanson, SY; Johnson, AC; Lund, S; Zager, RA | 1 |
| Beiras-Fernandez, A; Fuchs, H; Meiser, BM; Reichart, B; Weis, FC; Weis, M | 1 |
| Andrade, AC; Mebazaa, A; Tavares, M | 1 |
1 review(s) available for simendan and Ischemia
| Article | Year |
|---|---|
Levosimendan use in several scenarios of acute heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Contraindications; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypotension; Ischemia; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Syndrome; Vasodilator Agents | 2008 |
4 other study(ies) available for simendan and Ischemia
| Article | Year |
|---|---|
Oral application of levosimendan before ischaemia/reperfusion with or without cardioplegic arrest in rats.
Topics: Animals; Calcium; Cardioplegic Solutions; Drinking Water; Heart Arrest; Heart Arrest, Induced; Ischemia; Rats; Reperfusion; Simendan; Sodium Chloride; Troponin I | 2022 |
Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultured; Humans; Hypoxia; Induced Pluripotent Stem Cells; Ischemia; Lab-On-A-Chip Devices; Myocardial Ischemia; Myocytes, Cardiac; Simendan | 2022 |
Levosimendan protects against experimental endotoxemic acute renal failure.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Chemokine CCL2; Endotoxemia; Glyburide; Hydrazones; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Male; Mesangial Cells; Mice; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Tumor Necrosis Factor-alpha | 2006 |
Levosimendan treatment after primary organ failure in heart transplantation: a direct way to recovery?
Topics: Adolescent; Aged; Calcium; Cardiomyopathies; Catecholamines; Female; Heart; Heart Transplantation; Humans; Hydrazones; Ischemia; Male; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2006 |